PFOS, Ferroptosis, and ER Stress in HK-2 Cells

Perfluorooctane sulfonate (PFOS) is a persistent perfluorinated compound that can remain in environmental systems and accumulate in biological tissues. Because the kidney contributes substantially to PFOS excretion, renal tubular cells are an important model for defining its cellular toxicity. The study by Yan and colleagues, published in Toxicology and Industrial Health, examines whether PFOS injury in human proximal tubular HK-2 cells is associated with both ferroptosis and the endoplasmic reticulum stress pathway. The primary evidence is reported in the reference paper.

Study Background and Research Question

PFOS has been used in applications including surface treatment, cookware coatings, textiles, and food packaging because carbon–fluorine bonds provide exceptional chemical stability. That same stability limits hydrolysis, photolysis, microbial degradation, and metabolic breakdown. The reference study therefore frames PFOS not simply as an acute toxicant, but as a persistent exposure concern with potential consequences for organs involved in clearance.

The kidney is particularly relevant because PFOS can be eliminated through renal pathways and has been associated with renal abnormalities in experimental and epidemiological contexts. The authors selected HK-2 cells, an established human proximal tubular epithelial model, to ask a specific mechanistic question: does PFOS-induced tubular injury show the biochemical pattern of ferroptosis, and does it occur alongside activation of endoplasmic reticulum stress signaling?

Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lipid peroxidation and loss of antioxidant protection. Endoplasmic reticulum stress develops when protein-folding and homeostatic capacity is disturbed, activating the unfolded protein response through sensors such as PERK, IRE1, and ATF6. Examining these processes together is important because oxidative damage, iron dysregulation, membrane injury, and organelle stress can reinforce one another without establishing that every pathway is equally causal.

Key Innovation from the Reference Study

The main innovation is the study’s integrated readout of renal injury, ferroptosis-related biochemistry, and endoplasmic reticulum stress rather than reliance on a single nonspecific viability assay. KIM-1 was used as a marker of tubular injury, while malondialdehyde, glutathione, intracellular iron, and GPX4 provided complementary information about lipid oxidation, antioxidant capacity, iron handling, and ferroptosis defense.

In parallel, the authors measured GRP78 and the three major unfolded protein response branches represented by ATF6, IRE1, and PERK. This design places a renal injury marker beside molecular indicators from two mechanistically distinct but potentially connected stress programs. The inclusion of Fer-1, a ferroptosis-oriented pharmacological comparator, further moves the work beyond descriptive toxicology, although pharmacological intervention alone cannot fully establish pathway hierarchy.

This combination gives the paper practical value for environmental health researchers. It offers a compact experimental framework for determining whether a toxicant produces a ferroptosis-compatible phenotype while also activating endoplasmic reticulum stress. The findings do not demonstrate that PFOS is acting through one exclusive pathway; instead, they identify a coordinated cellular response that can be tested with more selective interventions.

Methods and Experimental Design Insights

HK-2 cells were treated with PFOS under the condition reported in the reference study, and a 1 μM Fer-1 condition was included as a ferroptosis-related comparison. The PFOS condition was 200 μM. Cell viability was assessed together with biochemical and protein-expression endpoints. According to the paper, the measured variables included MDA, reduced glutathione, total intracellular iron, GPX4, KIM-1, GRP78, ATF6, IRE1, and PERK.

The endpoint selection is useful because each measurement answers a different question. Viability indicates overall cell damage but does not identify its mode. MDA reflects lipid peroxidation, although it is not uniquely specific to ferroptosis. GSH and GPX4 represent an important antioxidant defense axis, while total iron indicates altered iron balance without necessarily measuring the labile iron pool. KIM-1 connects the biochemical response to a kidney-relevant injury phenotype. The ER-stress panel tests whether PFOS is associated with activation of the unfolded protein response.

Protocol Parameters

• Cellular model: Human proximal tubular epithelial HK-2 cells were used as the in vitro renal model, as reported in the reference study.
• PFOS exposure: The reported PFOS treatment condition was 200 μM; this is a study parameter and should not be interpreted as a direct estimate of human tissue exposure.
• Ferroptosis comparator: Fer-1 was used at 1 μM in the reported design as a pharmacological ferroptosis-related comparator.
• Core endpoint panel: Pair viability testing with MDA, GSH, total intracellular iron, GPX4, KIM-1, GRP78, ATF6, IRE1, and PERK measurements to preserve the study’s multilevel logic.
• Workflow extension: For follow-up work, include solvent-matched controls, untreated controls, biological replicates, and time-resolved sampling. These are recommended design practices rather than additional parameters reported by the paper.

Core Findings and Why They Matter

PFOS exposure significantly increased KIM-1 expression in HK-2 cells, supporting the presence of a renal tubular injury response. At the same time, MDA and total intracellular iron increased, whereas GSH and GPX4 decreased. This combination is consistent with enhanced iron-associated lipid peroxidation and weakened protection against phospholipid oxidation, the central biochemical pattern expected in ferroptosis.

The study also found increased expression of GRP78, ATF6, IRE1, and PERK after PFOS treatment. Together, these changes indicate activation of several arms of the unfolded protein response rather than an isolated alteration in one ER marker. The result is a coherent association between PFOS exposure, tubular injury, ferroptosis-associated redox disruption, and ER stress.

For nephrotoxicity research, the significance lies in connecting these layers. A decline in viability alone could reflect many forms of cellular damage. By adding iron, lipid peroxidation, antioxidant, injury-marker, and ER-stress measurements, the authors provide a more interpretable mechanistic profile. However, the results should be described as evidence that ferroptosis and ER stress participate in PFOS-associated injury, not as definitive proof that ER stress is upstream of ferroptosis or that all observed death is ferroptotic.

The findings also help distinguish this study from conventional apoptosis research. Ferroptosis is non-apoptotic, so increased cell injury does not automatically imply caspase-dependent apoptosis. Likewise, the reported endpoint set does not directly establish autophagic cell death modulation. Those processes would require dedicated assays and should not be inferred from the present protein panel.

Comparison with Existing Internal Articles

The internal article PFOS Triggers Ferroptosis and ER Stress in HK-2 Cells: Mechanistic Insights presents a closely aligned interpretation of the reference study, emphasizing the connection between ferroptosis-associated markers and ER-stress signaling. It is useful as a concise orientation piece, but the DOI-linked publication remains the appropriate source for experimental conditions, endpoint definitions, and the strength of the conclusions.

A second summary, PFOS-Induced Ferroptosis and ER Stress in HK-2 Cells, highlights the study’s value as an in vitro framework for environmental nephrotoxicity. That emphasis is consistent with the paper’s integrated design. Neither internal article should be treated as an independent replication; their value is interpretive and organizational, while the reference paper supplies the primary evidence.

Limitations and Transferability

The most immediate limitation is the use of an immortalized HK-2 monolayer. Such cells are useful for controlled mechanistic experiments but do not reproduce the architecture, filtration environment, immune interactions, metabolism, or exposure kinetics of a complete kidney. Results should therefore be transferred cautiously to animal models or human disease. The reference study itself notes that reported human serum PFOS concentrations are in the ng/mL range, whereas its cellular treatment condition is 200 μM; these values are not directly comparable because distribution, protein binding, accumulation, and exposure duration differ.

Several mechanistic uncertainties also remain. MDA is an informative oxidation-associated endpoint but is not unique to ferroptosis. Total intracellular iron does not define the redox-active iron pool, and GPX4 abundance does not necessarily equal GPX4 enzymatic activity. Similarly, increased GRP78, ATF6, IRE1, and PERK indicate ER-stress signaling but do not by themselves show whether the response is adaptive, terminal, or causally responsible for ferroptotic injury.

Fer-1 strengthens the experimental logic by providing a pathway-oriented pharmacological comparison, but a single inhibitor cannot resolve pathway order or exclude off-target effects. Stronger causal analysis would combine independent ferroptosis interventions with measurements of lipid reactive oxygen species, iron handling, mitochondrial or membrane changes, and carefully timed ER-stress perturbations. Dose–response and time-course experiments would also help distinguish early signaling events from downstream consequences. Finally, the study does not directly evaluate apoptosis or autophagy, so conclusions about those forms of cell death should remain outside its evidence base.

Research Support Resources

Why this cross-domain matters, maturity, and limitations

The reference study identifies ER stress as a relevant component of PFOS-associated HK-2 injury, but it does not test an ER-stress-modulating chemical chaperone. In a follow-up experiment, researchers can use 4-Phenylbutyric acid (4-PBA, SKU C6831) to support a hypothesis-testing workflow for ER stress alleviation, such as comparing PFOS alone with PFOS plus chemical chaperone while retaining the original KIM-1, ferroptosis, and unfolded protein response endpoints.

This application is exploratory rather than a validated treatment for PFOS toxicity. The product information reports purity of at least 98%, insolubility in water, and recommended storage at −20°C; solvent-matched controls are therefore important when preparing DMSO- or ethanol-based stocks. A 4-PBA arm may also help separate ER-stress contributions from other cell-death mechanisms, but it cannot by itself establish effects on apoptosis research or autophagic cell death modulation, neither of which was directly measured in the reference study.